Market Overview The biobanking market plays a crucial role in advancing biomedical research, precision medicine, and drug development by storing and managing biological samples such as blood, DNA, tissues, and cells. As personalized medicine and genomic research gain traction, the demand for high-quality, well-annotated biobanks is growing exponentially. The global biobanking market, valued at USD 25.09 billion in 2018, is expected to grow to USD 83.55 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.0% over the forecast period. Driven by government support, increased funding for clinical research, and rising awareness about the value of biospecimens, the market continues to evolve, with Europe holding a leading market share of 35.59% in 2018. The emergence of advanced technologies such as AI in biobank data analysis, cloud-based sample tracking, and blockchain for data integrity is reshaping the future of biobanking globally. Biobanking Market Overview Market Size and Growth Projections
Market Value in 2018: USD 25.09 Billion
Projected Market Value in 2032: USD 83.55 Billion
CAGR (2019–2032): 9.0%
The significant rise in market value is largely attributed to the increasing adoption of biobanking for drug discovery, chronic disease research, and personalized therapy. Governments and private organizations are increasingly investing in biobank infrastructure to enhance medical research capabilities, fueling market expansion. Regional Insights Europe: Leading the Global Market
Market Share in 2018: 35.59%
Europe is the frontrunner in the biobanking industry, supported by strong regulatory frameworks, advanced healthcare infrastructure, and substantial government and EU funding for biomedical research. Countries like the United Kingdom, Germany, Sweden, and Denmark host some of the most sophisticated biobanks, which contribute significantly to global clinical trials and epidemiological studies. North America and Asia-Pacific
North America follows closely, driven by high healthcare spending, extensive R&D activities, and collaborations between academia and pharmaceutical companies.
Asia-Pacific is witnessing rapid growth due to increasing investments in healthcare infrastructure, a growing patient population, and the adoption of precision medicine practices in countries like China, India, and Japan.
Market Drivers
Rising Demand for Personalized Medicine: Biobanks are critical to developing individualized treatment plans based on genetic information.
Growth in Genomic Research: The rise of genomics and proteomics research is increasing demand for high-quality biospecimens.
Government and Private Funding: Substantial investments are being made globally to establish and maintain biobanks.
Technological Advancements: Automation, AI, and blockchain are improving data management and sample tracking.
Increase in Chronic Diseases: Rising cases of cancer, diabetes, and cardiovascular conditions necessitate large-scale biobanking for research and treatment development.
Market Segmentation By Type
Population-Based Biobanks
Disease-Oriented Biobanks
By Specimen Type
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Others
By Application
Therapeutics
Clinical Research
Drug Discovery & Development
Life Science Research
By End User
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
CROs (Contract Research Organizations)
Recent Developments (2024–2025)
UK Biobank partnered with major pharmaceutical firms to accelerate drug discovery using genetic and health data from 500,000 participants.
Thermo Fisher Scientific launched new biobanking automation tools to streamline sample management and increase throughput.
BC Platforms, a health data management leader, introduced AI-powered data analysis for biobank samples, enhancing research efficiency.
China National GeneBank (CNGB) announced major expansion to house over 20 million biological samples to support genomic initiatives.
BioStorage Technologies introduced blockchain-based solutions to improve transparency and traceability in biobank data management.
Leading Key Players in 2025 1. Thermo Fisher Scientific Inc. 2. Brooks Life Sciences (Azenta Life Sciences) 3. Tecan Group Ltd. 4. Hamilton Company 5. QIAGEN N.V. 6. BioLife Solutions, Inc. 7. Greiner Bio-One International GmbH 8. Merck KGaA 9. UK Biobank 10. China National GeneBank (CNGB) These companies are focusing on strategic mergers, acquisitions, and technology integration to gain competitive advantages and meet the evolving demands of researchers and healthcare providers. Future Outlook The biobanking market is poised for robust growth, driven by the convergence of biotechnology, informatics, and data science. With increasing reliance on high-quality biospecimens for disease modeling and drug development, biobanks are becoming indispensable to the global healthcare ecosystem. The integration of artificial intelligence, machine learning, and cloud-based platforms will further optimize biobank operations, offering faster insights and improved research outcomes. 📑 Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/biobanking-market-102073 Conclusion The global biobanking market is entering a transformative phase with immense potential in personalized medicine, genomics, and pharmaceutical R&D. As the industry scales to meet future healthcare challenges, investments in infrastructure, data security, and international collaboration will be key. Stakeholders across academia, industry, and government must work together to ensure ethical, efficient, and sustainable biobanking practices that can drive innovation and improve global health outcomes. More Report:
Huntington’s Disease Treatment Market Application and Leading Players till 2032 Advanced Wound Dressings Market Global Analysis and Forecast 2032 U.S. Atrial Fibrillation Market Global Key Players, Industry Size by 2032 U.S. Colorectal Cancer Screening Market Segmentation, Opportunities, Forecast 2032 Amyotrophic Lateral Sclerosis Therapeutics Market Industry Size, Share, Growth and Forecast to 2032 U.S. Enteral Nutrition Products Market Size, Technology, Devices, Challenges 2032 US Speech Therapy Market Innovations, Challenges, and Opportunities 2032
